Demant A/S (CPH:DEMANT)
Denmark · Delayed Price · Currency is DKK 279.80
+0.80 (0.29%)
Jul 25, 2025, 4:59 PM CET
Demant Market Cap
Demant has a market cap or net worth of 57.56 billion as of July 25, 2025. Its market cap has decreased by -11.22% in one year.
Market Cap
57.56B
Enterprise Value
72.21B
Revenue
22.42B
Ranking
n/a
PE Ratio
21.02
Stock Price
279.80
Market Cap Chart
Since November 21, 1995, Demant's market cap has increased from 2.12B to 57.56B, an increase of 2,616.46%. That is a compound annual growth rate of 11.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 59.60B | 3.62% |
| Dec 30, 2024 | 57.52B | -10.34% |
| Dec 29, 2023 | 64.15B | 51.17% |
| Dec 30, 2022 | 42.43B | -47.09% |
| Dec 30, 2021 | 80.20B | 39.08% |
| Dec 30, 2020 | 57.66B | 12.05% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,984.48B |
| Coloplast | 139.69B |
| Genmab | 92.41B |
| ALK-Abelló | 43.68B |
| H. Lundbeck | 33.97B |
| Zealand Pharma | 27.46B |
| Ambu A/S | 27.25B |
| Bavarian Nordic | 18.14B |